Repros Therapeutics Inc.

REPROS THERAPEUTICS REPORTS MULTIPLE TRANSACTIONS BY 10 PERCENT OWNER EFFICACY CAPITAL (Texas)
US Fed News Service, Including US State News; 11/28/2009; 304 words; WASHINGTON, Nov. 28 -- Repros Therapeutics Inc. (RPRX), Woodlands, Texas, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results.(Financial report)
Biotech Week; 11/25/2009; 1542 words; Repros Therapeutics (NasdaqGM:RPRX) announced financial results for the third quarter...in clinical development activities for Androxal[R] (see also Repros Therapeutics). Research and Development expenses, or R&D, increased 41...

Mirna Therapeutics Appoints Dr. Paul Lammers as President and CEO.
Cancer Weekly; 11/24/2009; 1150 words; ...President & CEO of Mirna Therapeutics. "Based on Mirna...Prior to joining Mirna Therapeutics, Dr. Lammers was most recently president of Repros Therapeutics (Nasdaq:RPRX...officer for EMD Serono Inc. and began his career...

Repros Appoints Dr. Jaye Thompson to Board of Directors.
Clinical Trials Week; 11/23/2009; 791 words; Repros Therapeutics Inc. (NasdaqGM:RPRX) announced that it has elected Dr. Jaye Thompson...Board's Audit Committee, effective immediately (see also Repros Therapeutics Inc.). Dr. Thompson has previously assisted Repros in many of Repros...

News and FDA Updates for PharmAthene (NYSE:PIP), Repros Therapeutics (Nasdaq:RPRX).
M2 Presswire; 11/13/2009; 910 words; ...for PharmAthene (NYSE:PIP), Repros Therapeutics (Nasdaq:RPRX)(C)1994...On 12/11/09, PharmAthene, Inc. (NYSE:PIP), a biodefense...2009. On 12/11/09, Repros Therapeutics Inc. (Nasdaq:RPRX) announced...